Concept of the pathogenesis and treatment of cholelithiasis

World Journal of Hepatology

Volumn 4, Issue 2, 2012, Pages 18-34

  Reshetnyak, Vasiliy Ivanovich ^a  

^a V A NEGOVSKY RESEARCH INSTITUTE OF GENERAL REANIMATOLOGY   (Russian Federation)

Author keywords

Gallstone disease: epidemiology; Pathogenesis of cholesterol stones; Treatment

Indexed keywords

EID: 84871848389     PISSN: None     EISSN: 19485182     Source Type: Journal    
DOI: 10.4254/wjh.v4.i2.18     Document Type: Article

References (148)

1. Sun H, Tang H, Jiang S, Zeng L, Chen EQ, Zhou TY, Wang YJ. Gender and metabolic differences of gallstone diseases. World J Gastroenterol 2009; 15: 1886-1891
2. Conte D, Fraquelli M, Giunta M, Conti CB. Gallstones and liver disease: an overview. J Gastrointestin Liver Dis 2011; 20: 9-11
3. Belousov Yu V. Pediatric Gastroenterology. Up-to-date guide. Moscow: Exma, 2006: 112
4. Méndez-Sánchez N, Zamora-Valdés D, Flores-Rangel JA, Pérez-Sosa JA, Vásquez-Fernández F, Lezama-Mora JI, Vázquez-Elizondo G, Ponciano-Rodríguez G, Ramos MH, Uribe M. Gallstones are associated with carotid atherosclerosis. Liver Int 2008; 28: 402-406
5. Sánchez-Cuén J, Aguilar-Medina M, Arámbula-Meraz E, Romero-Navarro J, Granados J, Sicairos-Medina L, Ramos-Payán R. ApoB-100, ApoE and CYP7A1 gene polymorphisms in Mexican patients with cholesterol gallstone disease. World J Gastroenterol 2010; 16: 4685-4690
6. Temel RE, Brown JM. A new framework for reverse cholesterol transport: non-biliary contributions to reverse cholesterol transport. World J Gastroenterol 2010; 16: 5946-5952
7. Bagaudinov KG, Saidov SS, Garilevich BA, Zubkov AD, Abdulaev RA, Ovakimian GS. [Improvement of extracorporeal shockwave cholelithotripsy in the comprehensive treatment of cholelithiasis]. Klin Med (Mosk) 2007; 85: 56-59
8. Doggrell SA. New targets in and potential treatments for cholesterol gallstone disease. Curr Opin Investig Drugs 2006; 7: 344-348
9. Goldacre MJ, Duncan ME, Griffith M, Davidson M. Trends in mortality from appendicitis and from gallstone disease in English populations, 1979-2006: study of multiple-cause coding of deaths. Postgrad Med J 2011; 87: 245-250
10. Novacek G. Gender and gallstone disease. Wien Med Wochenschr 2006; 156: 527-533
11. Everhart JE, Khare M, Hill M, Maurer KR. Prevalence and ethnic differences in gallbladder disease in the United States. Gastroenterology 1999; 117: 632-639
12. Miquel JF, Covarrubias C, Villaroel L, Mingrone G, Greco AV, Puglielli L, Carvallo P, Marshall G, Del Pino G, Nervi F. Genetic epidemiology of cholesterol cholelithiasis among Chilean Hispanics, Amerindians, and Maoris. Gastroenterology 1998; 115: 937-946
13. Shaffer EA. Epidemiology and risk factors for gallstone disease: has the paradigm changed in the 21st century?. Curr Gastroenterol Rep 2005; 7: 132-140
14. Xu P, Yin XM, Zhang M, Liang YJ. [Epidemiology of gallstone in Nanjing City in China]. Zhonghua Liu Xing Bing Xue Za Zhi 2004; 25: 928
15. Sampliner RE, Bennett PH, Comess LJ, Rose FA, Burch TA. Gallbladder disease in pima indians. Demonstration of high prevalence and early onset by cholecystography. N Engl J Med 1970; 283: 1358-1364
16. Everhart JE, Yeh F, Lee ET, Hill MC, Fabsitz R, Howard BV, Welty TK. Prevalence of gallbladder disease in American Indian populations: findings from the Strong Heart Study. Hepatology 2002; 35: 1507-1512
17. Buch S, Schafmayer C, Völzke H, Becker C, Franke A, von Eller-Eberstein H, Kluck C, Bässmann I, Brosch M, Lammert F, Miquel JF, Nervi F, Wittig M, Rosskopf D, Timm B, Höll C, Seeger M, ElSharawy A, Lu T, Egberts J, Fändrich F, Fölsch UR, Krawczak M, Schreiber S, Nürnberg P, Tepel J, Hampe J. A genome-wide association scan identifies the hepatic cholesterol transporter ABCG8 as a susceptibility factor for human gallstone disease. Nat Genet 2007; 39: 995-999
18. Ahmed M, Diggory R. The correlation between ultrasonography and histology in the search for gallstones. Ann R Coll Surg Engl 2011; 93: 81-83
19. Stuart GS, Tang JH, Heartwell SF, Westhoff CL. A high cholecystectomy rate in a cohort of Mexican American women who are postpartum at the time of oral contraceptive pill initiation. Contraception 2007; 76: 357-359
20. Ruhl CE, Everhart JE. Gallstone disease is associated with increased mortality in the United States. Gastroenterology 2011; 140: 508-516
21. Tsukanov VV, Nozdrachev KG, Tonkikh IuL, Bronnikova EP, Kupershteie EIu. [The mechanism of reverse cholesterol transport and cholelithiasis in Northern ethnic groups]. Klin Med (Mosk) 2007; 85: 33-35
22. Ilychenko AA.. Gallstone disease. Lechashchiy Vrach 2004; 4: 27-33
23. Chong VH. Iatrogenic biliary stone. Surg Technol Int 2005; 14: 147-155
24. Völzke H, Baumeister SE, Alte D, Hoffmann W, Schwahn C, Simon P, John U, Lerch MM. Independent risk factors for gallstone formation in a region with high cholelithiasis prevalence. Digestion 2005; 71: 97-105
25. Cozcolluela Cabrejas MR, Sanz Salanova LA, Martínez-Berganza Asensio MT, Gómez Herrero H, Mellado Santos JM, Miranda Orella L, Forradellas Morales A. [Childhood cholelithiasis in a district hospital]. An Pediatr (Barc) 2007; 66: 611-614
26. Poddar U. Gallstone disease in children. Indian Pediatr 2010; 47: 945-953
27. Bergman S, Sourial N, Vedel I, Hanna WC, Fraser SA, Newman D, Bilek AJ, Galatas C, Marek JE, Monette J. Gallstone disease in the elderly: are older patients managed differently?. Surg Endosc 2011; 25: 55-61
28. Wang DQ. Aging per se is an independent risk factor for cholesterol gallstone formation in gallstone susceptible mice. J Lipid Res 2002; 43: 1950-1959
29. Grigorieva IN. Major risk factors of cholelithiasis. Rossiyskiy Zhurnal Gastroenterologii, Gepatologii i Koloproktologii 2007; 6: 17-19
30. He J, Nishida S, Xu M, Makishima M, Xie W. PXR prevents cholesterol gallstone disease by regulating biosynthesis and transport of bile salts. Gastroenterology 2011; 140: 2095-2106
31. Qin J, Han TQ, Fei J, Jiang ZY, Zhang Y, Yang SY, Jiang ZH, Cai XX, Huang W, Zhang SD. [Risk factors of familial gallstone disease: study of 135 pedigrees]. Zhonghua Yi Xue Za Zhi 2005; 85: 1966-1969
32. Abu-Eshy SA, Mahfouz AA, Badr A, El Gamal MN, Al-Shehri MY, Salati MI, Rabie ME. Prevalence and risk factors of gallstone disease in a high altitude Saudi population. East Mediterr Health J 2007; 13: 794-802
33. Ko CW. Risk factors for gallstone-related hospitalization during pregnancy and the postpartum. Am J Gastroenterol 2006; 101: 2263-2268
34. Marschall HU, Einarsson C. Gallstone disease. J Intern Med 2007; 261: 529-542
35. Cirillo DJ, Wallace RB, Rodabough RJ, Greenland P, LaCroix AZ, Limacher MC, Larson JC. Effect of estrogen therapy on gallbladder disease. JAMA 2005; 293: 330-339
36. Hart AR, Luben R, Welch A, Bingham S, Khaw KT. Hormone replacement therapy and symptomatic gallstones - a prospective population study in the EPIC-Norfolk cohort. Digestion 2008; 77: 4-9
37. Fornari F, Civardi G, Buscarini E, Cavanna L, Imberti D, Rossi S, Sbolli G, Di Stasi M, Buscarini L. Cirrhosis of the liver. A risk factor for development of cholelithiasis in males. Dig Dis Sci 1990; 35: 1403-1408
38. Zimmer V, Lammert F. Genetics in liver disease: new concepts. Curr Opin Gastroenterol 2011; 27: 231-239
39. Attili AF, De Santis A, Attili F, Roda E, Festi D, Carulli N. Prevalence of gallstone disease in first-degree relatives of patients with cholelithiasis. World J Gastroenterol 2005; 11: 6508-6511
40. Katsika D, Grjibovski A, Einarsson C, Lammert F, Lichtenstein P, Marschall HU. Genetic and environmental influences on symptomatic gallstone disease: a Swedish study of 43,141 twin pairs. Hepatology 2005; 41: 1138-1143
41. Khanuja B, Cheah YC, Hunt M, Nishina PM, Wang DQ, Chen HW, Billheimer JT, Carey MC, Paigen B. Lith1, a major gene affecting cholesterol gallstone formation among inbred strains of mice. Proc Natl Acad Sci USA 1995; 92: 7729-7733
42. Schafmayer C, Völzke H, Buch S, Egberts J, Spille A, von Eberstein H, Franke A, Seeger M, Hinz S, Elsharawy A, Rosskopf D, Brosch M, Krawczak M, Foelsch UR, Schafmayer A, Lammert F, Schreiber S, Faendrich F, Hampe J, Tepel J. Investigation of the Lith6 candidate genes APOBEC1 and PPARG in human gallstone disease. Liver Int 2007; 27: 910-919
43. Kovacs P, Kress R, Rocha J, Kurtz U, Miquel JF, Nervi F, Méndez-Sánchez N, Uribe M, Bock HH, Schirin-Sokhan R, Stumvoll M, Mössner J, Lammert F, Wittenburg H. Variation of the gene encoding the nuclear bile salt receptor FXR and gallstone susceptibility in mice and humans. J Hepatol 2008; 48: 116-124
44. Grünhage F, Acalovschi M, Tirziu S, Walier M, Wienker TF, Ciocan A, Mosteanu O, Sauerbruch T, Lammert F. Increased gallstone risk in humans conferred by common variant of hepatic ATP-binding cassette transporter for cholesterol. Hepatology 2007; 46: 793-801
45. Kuo KK, Shin SJ, Chen ZC, Yang YH, Yang JF, Hsiao PJ. Significant association of ABCG5 604Q and ABCG8 D19H polymorphisms with gallstone disease. Br J Surg 2008; 95: 1005-1011
46. Wang Y, Jiang ZY, Fei J, Xin L, Cai Q, Jiang ZH, Zhu ZG, Han TQ, Zhang SD. ATP binding cassette G8 T400K polymorphism may affect the risk of gallstone disease among Chinese males. Clin Chim Acta 2007; 384: 80-85
47. Qin J, Han TQ, Yuan WT, Fei J, Jiang ZH, Zhang J, Wang Y, Huang W, Zhang SD. [Study on the position of genes responsible for gallstone disease in Chinese population]. Zhonghua Wai Ke Za Zhi 2006; 44: 485-487
48. Kharitonova LA. Cholelithiasis in children: issues of choice of therapeutic tactics. Russkiy Meditsinskiy Zhurnal 2003; 11: 787-790
49. Andreotti G, Chen J, Gao YT, Rashid A, Chen BE, Rosenberg P, Sakoda LC, Deng J, Shen MC, Wang BS, Han TQ, Zhang BH, Yeager M, Welch R, Chanock S, Fraumeni JF, Hsing AW. Polymorphisms of genes in the lipid metabolism pathway and risk of biliary tract cancers and stones: a population-based case-control study in Shanghai, China. Cancer Epidemiol Biomarkers Prev 2008; 17: 525-534
50. Báez S, Tsuchiya Y, Calvo A, Pruyas M, Nakamura K, Kiyohara C, Oyama M, Yamamoto M. Genetic variants involved in gallstone formation and capsaicin metabolism, and the risk of gallbladder cancer in Chilean women. World J Gastroenterol 2010; 16: 372-378
51. Dixit M, Choudhuri G, Saxena R, Mittal B. Association of apolipoprotein A1-C3 gene cluster polymorphisms with gallstone disease. Can J Gastroenterol 2007; 21: 569-575
52. Juzyszyn Z, Kurzawski M, Modrzejewski A, Sulikowski T, Pawlik A, Czerny B, Drozdzik M. Low-density lipoprotein receptor-related protein-associated protein (LRPAP1) gene IVS5 insertion/deletion polymorphism is not a risk factor for gallstone disease in a Polish population. Dig Liver Dis 2008; 40: 122-125
53. Mbongo-Kama E, Harnois F, Mennecier D, Leclercq E, Burnat P, Ceppa F. MDR3 mutations associated with intrahepatic and gallbladder cholesterol cholelithiasis: an update. Ann Hepatol 2007; 6: 143-149
54. Rosmorduc O, Poupon R. Low phospholipid associated cholelithiasis: association with mutation in the MDR3/ABCB4 gene. Orphanet J Rare Dis 2007; 2: 29
55. Kim HJ, Kim SH, Chae GB, Lee SJ, Kang CD. Increased expression of mucin 5AC mRNA and decreased expression of epidermal growth-factor receptor mRNA in gallstone patients. Tohoku J Exp Med 2008; 214: 139-144
56. Chuang SC, Juo SH, Hsi E, Wang SN, Tsai PC, Yu ML, Lee KT. Multiple mucin genes polymorphisms are associated with gallstone disease in Chinese men. Clin Chim Acta 2011; 412: 599-603
57. Chang TS, Lo SK, Shyr HY, Fang JT, Lee WC, Tai DI, Sheen IS, Lin DY, Chu CM, Liaw YF. Hepatitis C virus infection facilitates gallstone formation. J Gastroenterol Hepatol 2005; 20: 1416-1421
58. Tsai CJ, Leitzmann MF, Willett WC, Giovannucci EL. Weight cycling and risk of gallstone disease in men. Arch Intern Med 2006; 166: 2369-2374
59. Klass DM, Lauer N, Hay B, Kratzer W, Fuchs M. Arg64 variant of the beta3-adrenergic receptor is associated with gallstone formation. Am J Gastroenterol 2007; 102: 2482-2487
60. Leitzmann MF, Willett WC, Rimm EB, Stampfer MJ, Spiegelman D, Colditz GA, Giovannucci E. A prospective study of coffee consumption and the risk of symptomatic gallstone disease in men. JAMA 1999; 281: 2106-2112
61. Zhang Y, Liu D, Ma Q, Dang C, Wei W, Chen W. Factors influencing the prevalence of gallstones in liver cirrhosis. J Gastroenterol Hepatol 2006; 21: 1455-1458
62. Déry L, Galambos Z, Kupcsulik P, Lukovich P. [Cirrhosisand cholelithiasis. Laparoscopic or open cholecystectomy?.]. Orv Hetil 2008; 149: 2129-2134
63. Hsing AW, Gao YT, McGlynn KA, Niwa S, Zhang M, Han TQ, Wang BS, Chen J, Sakoda LC, Shen MC, Zhang BH, Deng J, Rashid A. Biliary tract cancer and stones in relation to chronic liver conditions: A population-based study in Shanghai, China. Int J Cancer 2007; 120: 1981-1985
64. Loria P, Lonardo A, Lombardini S, Carulli L, Verrone A, Ganazzi D, Rudilosso A, D'Amico R, Bertolotti M, Carulli N. Gallstone disease in non-alcoholic fatty liver: prevalence and associated factors. J Gastroenterol Hepatol 2005; 20: 1176-1184
65. Guraya SY. Reappraisal of the management of cholelithiasis in diabetics. Saudi Med J 2005; 26: 1691-1694
66. Chang SC, Rashid A, Gao YT, Andreotti G, Shen MC, Wang BS, Han TQ, Zhang BH, Sakoda LC, Leitzmann MF, Chen BE, Rosenberg PS, Chen J, Chanock SJ, Hsing AW. Polymorphism of genes related to insulin sensitivity and the risk of biliary tract cancer and biliary stone: a population-based case-control study in Shanghai, China. Carcinogenesis 2008; 29: 944-948
67. Paisley AN, Roberts ME, Trainer PJ. Withdrawal of somatostatin analogue therapy in patients with acromegaly is associated with an increased risk of acute biliary problems. Clin Endocrinol (Oxf) 2007; 66: 723-726
68. Davidson MH, Armani A, McKenney JM, Jacobson TA. Safety considerations with fibrate therapy. Am J Cardiol 2007; 99: 3C-18C
69. Schiemann U, Ferhat A, Götzberger M, Kaiser C, Stief J, Landgraf R, Dieterle C. Prevalence of cholecystolithiasis and its management among kidney/pancreas-transplanted type 1 (insulin-dependent) diabetic patients. Eur J Med Res 2008; 13: 127-130
70. Khan MK, Jalil MA, Khan MS. Oral contraceptives in gall stone diseases. Mymensingh Med J 2007; 16: S40-S45
71. Reshetnyak TM, Saparin GV, Ivannikov PV, Reshetnyak VI. Corticosteroids and Cholelithiasis in Systemic Lupus Erythematosus. Scholarly Research Exchange 2009; 2009: 9
72. Sherlock S, Dooley J. Diseases of the liver and biliary system. 9th ed. Oxford: Blackwell Sci Pub, 1993: 44-58
73. Soysal A, Erasov K, Akpinar I, Bakir M. Biliary precipitation during ceftriaxone therapy: frequency and risk factors. Turk J Pediatr 2007; 49: 404-407
74. Liu CM, Tung TH, Tsai ST, Liu JH, Tsai YK, Chen VT, Tam TN, Lu HF, Wang KK, Hsu CT, Shih HC, Chan DC, Chou P. Serum insulin, insulin resistance, beta-cell dysfunction, and gallstone disease among type 2 diabetics in Chinese population: a community-based study in Kinmen, Taiwan. World J Gastroenterol 2005; 11: 7159-7164
75. Chang Y, Sung E, Ryu S, Park YW, Jang YM, Park M. Insulin resistance is associated with gallstones even in non-obese, non-diabetic Korean men. J Korean Med Sci 2008; 23: 644-650
76. Pullinger CR, Eng C, Salen G, Shefer S, Batta AK, Erickson SK, Verhagen A, Rivera CR, Mulvihill SJ, Malloy MJ, Kane JP. Human cholesterol 7alpha-hydroxylase (CYP7A1) deficiency has a hypercholesterolemic phenotype. J Clin Invest 2002; 110: 109-117
77. Monte MJ, Marin JJ, Antelo A, Vazquez-Tato J. Bile acids: chemistry, physiology, and pathophysiology. World J Gastroenterol 2009; 15: 804-816
78. Kitsiou-Tzeli S, Giannatou E, Spanos I, Nicolaidou P, Fretzayas A, Tzetis M, Lazaris D, Kanavakis E, Tsezou A. Steroid hormones polymorphisms and cholelithiasis in Greek population. Liver Int 2007; 27: 61-68
79. Momiyama M, Wakai K, Oda K, Kamiya J, Ohno Y, Hamaguchi M, Nakanuma Y, Hsieh LL, Yeh TS, Chen TC, Jan YY, Chen MF, Nimura Y. Lifestyle risk factors for intrahepatic stone: findings from a case-control study in an endemic area, Taiwan. J Gastroenterol Hepatol 2008; 23: 1075-1081
80. Vilkin A, Geller A, Levi Z, Niv Y. Mucin gene expression in bile of patients with and without gallstone disease, collected by endoscopic retrograde cholangiography. World J Gastroenterol 2009; 15: 2367-2371
81. Sasaki M, Nakanuma Y, Kim YS. Expression of apomucins in the intrahepatic biliary tree in hepatolithiasis differs from that in normal liver and extrahepatic biliary obstruction. Hepatology 1998; 27: 54-61
82. Wang HH, Afdhal NH, Gendler SJ, Wang DQ. Targeted disruption of the murine mucin gene 1 decreases susceptibility to cholesterol gallstone formation. J Lipid Res 2004; 45: 438-447
83. Maximenko VB. Impaired concentration and motor evacuatory functions of the gallbladder in cholecystolithiasis. Rossiyskiy Zhurnal Gastroenterologii, Gepatologii i Koloproktologii 2006; 4: 24-28
84. Cerçi SS, Ozbek FM, Cerçi C, Baykal B, Eroglu HE, Baykal Z, Yildiz M, Saglam S, Yesildag A. Gallbladder function and dynamics of bile flow in asymptomatic gallstone disease. World J Gastroenterol 2009; 15: 2763-2767
85. Huang SM, Yao CC, Pan H, Hsiao KM, Yu JK, Lai TJ, Huang SD. Pathophysiological significance of gallbladder volume changes in gallstone diseases. World J Gastroenterol 2010; 16: 4341-4347
86. Olokoba AB, Bojuwoye BJ, Olokoba LB, Wahab KW, Salami AK, Braimoh KT, Inikori AK. The relationship between gallstone disease and gall bladder volume. Niger J Clin Pract 2008; 11: 89-93
87. Bolukbas FF, Bolukbas C, Horoz M, Ince AT, Uzunkoy A, Ozturk A, Aka N, Demirci F, Inci E, Ovunc O. Risk factors associated with gallstone and biliary sludge formation during pregnancy. J Gastroenterol Hepatol 2006; 21: 1150-1153
88. Pamuk GE, Umit H, Harmandar F, Yesil N. Patients with iron deficiency anemia have an increased prevalence of gallstones. Ann Hematol 2009; 88: 17-20
89. Mansurov KhKh, Mirodzhov GK. Pathogenetic therapy for gallbladder cholesterosis. Rossiyskiy Zhurnal Gastroenterologii, Gepatologii i Koloproktologii 2005; 6: 45-48
90. Srivastava A, Pandey SN, Dixit M, Choudhuri G, Mittal B. Cholecystokinin receptor A gene polymorphism in gallstone disease and gallbladder cancer. J Gastroenterol Hepatol 2008; 23: 970-975
91. Zhang ZH, Wu SD, Gao H, Shi G, Jin JZ, Kong J, Tian Z, Su Y. Expression of pituitary adenylate cyclase-activating polypeptide 1 and 2 receptor mRNA in gallbladder tissue of patients with gallstone or gallbladder polyps. World J Gastroenterol 2006; 12: 1468-1471
92. Xiao Z, Schmitz F, Pricolo VE, Biancani P, Behar J. Role of caveolae in the pathogenesis of cholesterol-induced gallbladder muscle hypomotility. Am J Physiol Gastrointest Liver Physiol 2007; 292: G1641-G1649
93. Yi SQ, Ohta T, Tsuchida A, Terayama H, Naito M, Li J, Wang HX, Yi N, Tanaka S, Itoh M. Surgical anatomy of innervation of the gallbladder in humans and Suncus murinus with special reference to morphological understanding of gallstone formation after gastrectomy. World J Gastroenterol 2007; 13: 2066-2071
94. Kobayashi T, Hisanaga M, Kanehiro H, Yamada Y, Ko S, Nakajima Y. Analysis of risk factors for the development of gallstones after gastrectomy. Br J Surg 2005; 92: 1399-1403
95. Nakamura K, Ogoshi K, Makuuchi H. Clinicopathological study of cholelithiasis following gastric cancer surgery. Eur Surg Res 2005; 37: 29-35
96. Quesada BM, Kohan G, Roff HE, Canullán CM, Chiappetta Porras LT. Management of gallstones and gallbladder disease in patients undergoing gastric bypass. World J Gastroenterol 2010; 16: 2075-2079
97. Crema E, Ribeiro LB, Adad SJ, Ectchebehere RM, Martins Júnior A, Silva AA. Gallbladder neuron count in cholelithiasis patients with and without Chagas disease. Rev Soc Bras Med Trop 2007; 40: 15-17
98. vanBerge-Henegouwen GP, Venneman NG, van ErpecumKJ, Portincasa P. Drugs affecting biliary lipid secretion and gallbladder motility: their potential role in gallstone treatment and prevention. Curr Drug Targets Immune Endocr Metabol Disord 2005; 5: 185-191
99. Loginov AS, Chebanov SM, Marakhovskii IuKh, Goncharik II. [Microstructure of vesicular agglomerates of the lithogenic bile]. Biull Eksp Biol Med 1989; 108: 251-254
100. Loginov AS, Chebanov SM, Petrakov AV, Saparin GV, Obyden SK, Ivannikov PV. Investigation of cholesterol, bilirubin, and protein distribution in human gallstones by color cathodoluminescence scanning electron microscopy and transmission electron microscopy. Scanning 1998; 20: 17-22
101. Loginov AS, Chebanov SM, Saparin GV, Obyden SK, Reshetnyak VI. Microstructure of gallstones according to the color cathodoluminescence scanning electron microscopy. Russian Gastroenterol J 1998; 4: 26-29
102. Isayeva GSh. Possible involvement of Helicobacter bacteria in the pathogenesis of hepatobiliary diseases. Rossiyskiy Zhurnal Gastroenterologii, Gepatologii i Koloproktologii 2008; 4: 14-22
103. Vasavda N, Menzel S, Kondaveeti S, Maytham E, Awogbade M, Bannister S, Cunningham J, Eichholz A, Daniel Y, Okpala I, Fulford T, Thein SL. The linear effects of alpha-thalassaemia, the UGT1A1 and HMOX1 polymorphisms on cholelithiasis in sickle cell disease. Br J Haematol 2007; 138: 263-270
104. Leff DR, Kaura T, Agarwal T, Davies SC, Howard J, Chang AC. A nontransfusional perioperative management regimen for patients with sickle cell disease undergoing laparoscopic cholecystectomy. Surg Endosc 2007; 21: 1117-1121
105. Origa R, Galanello R, Perseu L, Tavazzi D, Domenica Cappellini M, Terenzani L, Forni GL, Quarta G, Boetti T, Piga A. Cholelithiasis in thalassemia major. Eur J Haematol 2009; 82: 22-25
106. Tankanitlert J, Morales NP, Fucharoen P, Fucharoen S, Chantharaksri U. Association between promoter and coding region mutations of UDP-glucuronosyltransferase 1A1 and beta-thalassemia/Hb E with cholelithiasis. Eur J Haematol 2008; 80: 351-355
107. Uchiyama K, Kawai M, Tani M, Terasawa H, Tanimura H, Yamaue H. Pathogenesis of hepatolithiasis based on the analysis of components of intrahepatic stones. Hepatogastroenterology 2007; 54: 1798-1804
108. Sayers C, Wyatt J, Soloway RD, Taylor DR, Stringer MD. Gallbladder mucin production and calcium carbonate gallstones in children. Pediatr Surg Int 2007; 23: 219-223
109. Kaur T, Kaur S. Pathophysiological conditions in cholelithiasis formation in North Indian population: spectroscopic, biophysical, and biochemical study. Biol Trace Elem Res 2010; 138: 79-89
110. Carey MC. Pathogenesis of gallstones. Am J Surg 1993; 165: 410-419
111. Dikkers A, Tietge UJ. Biliary cholesterol secretion: more than a simple ABC. World J Gastroenterol 2010; 16: 5936-5945
112. Claudel T, Zollner G, Wagner M, Trauner M. Role of nuclear receptors for bile acid metabolism, bile secretion, cholestasis, and gallstone disease. Biochim Biophys Acta 2011; 1812: 867-878
113. Small DM. The staging of cholesterol gallstones with respect to nucleation and growth. In: Paumgartner J, Stiehl A, Gerok W, editors. Falk Symposium 29. Bile acids and lipids. England: MTP Press Limited, 1981: 291-300
114. Carey MC, Cohen D. Biliary transport of cholesterol in vesicles, micelles and liquid crystals. In: Paumgartner G, Stiehl A, Gerok W, editors. Falk Symposium 45. Bile Acids and the Liver. England: MTP Press Limited, 1987: 287-300
115. Cohen DE, Kaler EW, Carey MC. Cholesterol carriers in human bile: are "lamellae" involved?. Hepatology 1993; 18: 1522-1531
116. Been JM, Bills PM, Lewis D. Microstructure of gallstones. Gastroenterology 1979; 76: 548-555
117. Chijiiwa K, Hirota I, Noshiro H. High vesicular cholesterol and protein in bile are associated with formation of cholesterol but not pigment gallstones. Dig Dis Sci 1993; 38: 161-166
118. Holan KR, Holzbach RT, Hermann RE, Cooperman AM, Claffey WJ. Nucleation time: a key factor in the pathogenesis of cholesterol gallstone disease. Gastroenterology 1979; 77: 611-617
119. Konikoff FM, Cohen DE, Carey MC. Phospholipid molecular species influence crystal habits and transition sequences of metastable intermediates during cholesterol crystallization from bile salt-rich model bile. J Lipid Res 1994; 35: 60-70
120. Loginov AS, Chebanov SM, Saparin GV, Obyden SK. The morphology and composition of cholesterol, protein, and bilirubin deposits in dried human bile: cathodoluminescence and backscattered electron imaging. Scanning 1998; 20: 442-446
121. Jüngst C, Sreejayan N, Eder MI, von Stillfried N, Zündt B, Spelsberg FW, Kullak-Ublick GA, Jüngst D, von Ritter C. Lipid peroxidation and mucin secretagogue activity in bile of gallstone patients. Eur J Clin Invest 2007; 37: 731-736
122. Hofmann AF. Biliary secretion and excretion in health and disease: current concepts. Ann Hepatol 2007; 6: 15-27
123. Wu SD, Yu H, Sun JM. Bacteriological and electron microscopic examination of primary intrahepatic stones. Hepatobiliary Pancreat Dis Int 2006; 5: 228-231
124. Manolis EN, Filippou DK, Papadopoulos VP, Kaklamanos I, Katostaras T, Christianakis E, Bonatsos G, Tsakris A. The culture site of the gallbladder affects recovery of bacteria in symptomatic cholelithiasis. J Gastrointestin Liver Dis 2008; 17: 179-182
125. Crawford RW, Gibson DL, Kay WW, Gunn JS. Identification of a bile-induced exopolysaccharide required for Salmonella biofilm formation on gallstone surfaces. Infect Immun 2008; 76: 5341-5349
126. Stewart L, Griffiss JM, Jarvis GA, Way LW. Bacteria entombed in the center of cholesterol gallstones induce fewer infectious manifestations than bacteria in the matrix of pigment stones. J Gastrointest Surg 2007; 11: 1298-1308
127. Stewart L, Grifiss JM, Jarvis GA, Way LW. Biliary bacterial factors determine the path of gallstone formation. Am J Surg 2006; 192: 598-603
128. Jang JS, Kim KH, Yu JR, Lee SU. Identification of parasite DNA in common bile duct stones by PCR and DNA sequencing. Korean J Parasitol 2007; 45: 301-306
129. Choi D, Lim JH, Lee KT, Lee JK, Choi SH, Heo JS, Choi DW, Jang KT, Lee NY, Kim S, Hong ST. Gallstones and Clonorchis sinensis infection: a hospital-based case-control study in Korea. J Gastroenterol Hepatol 2008; 23: e399-e404
130. Mayev IV, Dicheva DT, Buragina TA. Diagnosis and treatment of biliary sludge in patients with ulcerative disease. Rossiyskiy Zhurnal Gastroenterologii, Gepatologii i Koloproktologii 2007; 4: 68-72
131. Mekhtiyev SN, Grinevich VB, Kravchuk YuA, Bogdanov RN. Biliary sludge: unsolved problems. Lechashchiy Vrach 2007; 6: 24-28
132. Marschall HU, Wagner M, Zollner G, Fickert P, Diczfalusy U, Gumhold J, Silbert D, Fuchsbichler A, Benthin L, Grundström R, Gustafsson U, Sahlin S, Einarsson C, Trauner M. Complementary stimulation of hepatobiliary transport and detoxification systems by rifampicin and ursodeoxycholic acid in humans. Gastroenterology 2005; 129: 476-485
133. Jüngst C, Sreejayan N, Zündt B, Müller I, Spelsberg FW, Hüttl TP, Kullak-Ublick GA, del Pozo R, Jüngst D, von Ritter C. Ursodeoxycholic acid reduces lipid peroxidation and mucin secretagogue activity in gallbladder bile of patients with cholesterol gallstones. Eur J Clin Invest 2008; 38: 634-639
134. Guarino MP, Carotti S, Sarzano M, Alloni R, Vanni M, Grosso M, Sironi G, Maffettone PL, Cicala M. Short-term ursodeoxycholic acid treatment improves gallbladder bileturnover in gallstone patients: a randomized trial. Neurogastroenterol Motil 2005; 17: 680-686
135. Mas MR, Comert B, Mas N, Yamanel L, Ozotuk H, Tasci I, Jazrawi RP. Effects of long term hydrophilic bile acid therapy on in vitro contraction of gallbladder muscle strips in patients with cholesterol gallstones. World J Gastroenterol 2007; 13: 4336-4339
136. Stawarski A, Iwanczak B, Iwanczak F. [Predisposing factors and results of pharmalogical treatment using ursodeoxycholic acid of gallbladder stones in children]. Pol Merkur Lekarski 2006; 20: 199-202
137. Keizman D, Goldiner I, Leikin-Frenkel A, Konikoff FM. [Innovations in the medical treatment of gallstones and fatty liver: FABACs (Fatty Acid Bile Acid Conjugates)]. Harefuah 2008; 147: 344-39, 373, 372
138. Rabenstein T, Radespiel-Tröger M, Höpfner L, Benninger J, Farnbacher M, Greess H, Lenz M, Hahn EG, Schneider HT. Ten years experience with piezoelectric extracorporeal shockwave lithotripsy of gallbladder stones. Eur J Gastroenterol Hepatol 2005; 17: 629-639
139. Amplatz S, Piazzi L, Felder M, Comberlato M, Benvenuti S, Zancanella L, Di Fede F, de'Guelmi A, Bertozzo A, Farris P, Grasso T, Mega A, Chilovi F. Extracorporeal shock wave lithotripsy for clearance of refractory bile duct stones. Dig Liver Dis 2007; 39: 267-272
140. Carrilho-Ribeiro L, Pinto-Correia A, Velosa J, Carneiro De Moura M. A ten-year prospective study on gallbladder stone recurrence after successful extracorporeal shock-wave lithotripsy. Scand J Gastroenterol 2006; 41: 338-342
141. Xu Z, Wang LX, Zhang NW, Hou CS, Ling XF, Xu Y, Zhou XS. Clinical application of plasma shock wave lithotripsy in treating impacted stones in the bile duct system. World J Gastroenterol 2006; 12: 130-133
142. Shim CS, Moon JH, Cho YD, Kim YS, Hong SJ, Kim JO, Cho JY, Kim YS, Lee JS, Lee MS. The role of extracorporeal shock wave lithotripsy combined with endoscopic management of impacted cystic duct stones in patients with high surgical risk. Hepatogastroenterology 2005; 52: 1026-1029
143. Ahmed MH. Ezetimbe as potential treatment for cholesterol gallstones: the need for clinical trials. World J Gastroenterol 2010; 16: 1555-1557
144. Zúñiga S, Molina H, Azocar L, Amigo L, Nervi F, Pimentel F, Jarufe N, Arrese M, Lammert F, Miquel JF. Ezetimibe prevents cholesterol gallstone formation in mice. Liver Int 2008; 28: 935-947
145. Wang HH, Portincasa P, Mendez-Sanchez N, Uribe M, Wang DQ. Effect of ezetimibe on the prevention and dissolution of cholesterol gallstones. Gastroenterology 2008; 134: 2101-2110
146. Ko CW. Magnesium: does a mineral prevent gallstones?. Am J Gastroenterol 2008; 103: 383-385
147. Tsai CJ, Leitzmann MF, Willett WC, Giovannucci EL. Long-term effect of magnesium consumption on the risk of symptomatic gallstone disease among men. Am J Gastroenterol 2008; 103: 375-382
148. Koppisetti S, Jenigiri B, Terron MP, Tengattini S, Tamura H, Flores LJ, Tan DX, Reiter RJ. Reactive oxygen species and the hypomotility of the gall bladder as targets for the treatment of gallstones with melatonin: a review. Dig Dis Sci 2008; 53: 2592-2603